urines containing the 5.0 g/L concentrations of glucose produced readings of 2.5 g/L. Neither method showed interference from 0.1 or 0.2 g of ascorbic acid per liter.
Indican Interference with Six Commercial Procedures for Measuring Total Bilirubin

R. Poon and I. H. Hlnberg1
We have studied the effect of indican on six commercial procedures for the measurement of total bilirubin in serum. Total bilirubin measured by the Bilirubin A-Gent'" (Abbott hausen et al. (4) , that the determination of total bilirubin by a procedure involving 2,4-dichlorophenyl diazonium (2,4-DCPD) gave falsely increased results in the presence of indican, no attention has since been paid to this interferent.
We have studied the effect of indican on six commercial colorimetric procedures for the measurement of total bilirubin in serum and report our findings. We prepared samples with indican concentrations between 0 and 0.92 mmol/L by adding appropriate volumes of a 47 mmol/L solution of indican to aliquots of pooled human serum. The manual and automated colorimetric bilirubin measurement procedures we studied are described in Table  1 . The kit manufacturers' directions for use were strictly followed. Where calibrators were not provided, we used bilirubin standards in bovine serum albumin, 40 g/L, prepared as described by Perry et al.
Materials and Methods
Indican
(5).
Stabilizer-free 2,4-DCPD reagent was prepared at room temperature by adding sodium nitrite (final concentration, 10 MlnolJL) to a solution containing 2 minol of 2,4-dichloroaniline and 69 minol of sulfamic acid per liter of water! methanol (1/1, by vol). We used the reagent 2 mm after adding the sodium nitrite.
To measure absorbance, we used a Beckman DU-8B spectrophotometer (Beckman Instruments Inc., Fullerton, CA 92634); difference spectra were obtained with a Cary 219 spectrophotometer (Varian Associates Inc., Palo Alto, CA 94303). 
Results
Our results ( . Bottom, reactionof2,5-DCPDwith samesolutions of bilirubin (-) and jndican (---, 5 mm after mixing;-., 30 mm after mixing).
Referencecell:diazoniumreagentplusalbumin(40 g/L)
DCPD procedures in the presence of indican. Both color complexes were stable for at least 30 mm.
Although the 2,5-DCPD reagent is structurally similar to the 2,4-DCPD reagent, it forms different color complexes with bilirubin and indican (Figure 2, bottom) . As shown previously by Wahlefeld et al. (7) , the 2,5-DCPD reagent reacted with bilirubin to produce a color complex with maximum absorbance at 520 rim that was stable for at least 30 mm. In contrast, the color complex initially formed by reaction of the 2,5-DCPD reagent with indican had absor-bance bands with maximum absorbances at 375, 460, and 530 nm; the absorbance of the 460 nm band decreased with time, while that of the 530 nm band increased to almost twice its initial value after 30 mm (Figure 2, bottom) .
Because it is this band at 520 nm that is responsible for the interference of indican with the measurement of total bilirubin by 2,5-DCPD procedure, the amount of interference will increase significantly as color development is prolonged.
The absorbance spectra in Figure 2 were obtained with commercial 2,4-DCPD and 2,5-DCPD reagents (Table 1) . Because the commercial 2,4.-DCPD reagent used contained a stabilizer, probably 1,5-naphthalenedisulfonate (4), we also conducted studies with stabilizer-free 2,4-DCPD reagent. This reagent reacted with bilirubin and indican to produce color complexes with absorbance spectra identical to those in Figure 2 (top) .
In the Malloy-Evelyn procedure, bilirubin reacts with pdiazobenzenesulfonic reagent to form a color complex with a maximum absorbance at 560 nun. Indican also reacts with the reagent, to give peak absorbances at 380 and 490 rim. However, the 490-nun peak had near-baseline absorbance at 560 nm and therefore only minimally influenced biirubin measurement.
In the Jendrassik-Grof procedure, bilirubin reacts to form a broad absorbance band from 400 to 700 nun with peak absorbance at 595 nm. Indican does not react to produce a color complex in this wavelength range.
Discussion
Only the 2,4-DCPD and 2,5-DCPD procedures for determining bilirubin were markedly affected by indican, which reacted with the reagents to form color complexes that absorbed significantly at the wavelengths used for the measurement of bilirubin, thereby producing falsely high results.
Concentrations of indicart as high as 0.38 mmol/L have been found in sera of patients with chronic renal failure (4). Our results show that this concentration would increase total bilirubin values measured by the 2,4-DCPD and 2,5-DCPD diazonium procedures by more than 19 and 12 mg/L, respectively. Because a total bilirubin value of 15 mg/L is generally considered abnormally high (8), the interference of indican with these procedures may lead to false presumptive diagnoses of liver abnormalities in these patients, necessitating time-consuming, expensive, and hazardous additional diagnostic procedures.
Because of their relative stability and the speed with which they react with bilirubin, both the 2,4-DCPD and 2,5-DCPD procedures are widely used in automated and manual procedures for total bilirubin (4, 9, 10). Users of these reagents should be suspicious of unexpectedly high values for bilirubin in sera from uremic patients.
